Skip to nav Skip to content

Clinical Trial Search

376 Clinical Trials Found

Clinical Trial 23441

Phase 1/1b Study of AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Cancer
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
PI: Yang, George

Clinical Trial 23579

A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination with Standard of Care Immunotherapy in Participants with Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02
Disease Site: Lung
PI: Gray, Jhanelle

Clinical Trial 23587

Disease Site: Other
PI: Wenham, Robert

Clinical Trial 21710

Disease Site: Non-Hodgkin's Lymphoma
PI: Gaballa, Sameh

Clinical Trial 21731

A Phase II Trial of Olaparib in Combination with Pembrolizumab for Advanced Uveal Melanoma
Disease Site: Melanoma, skin
PI: Khushalani, Nikhil

Clinical Trial 21757

Phase II Study of Genomically Guided Radiation Dose Personalization in the Management of Triple Negative Breast Cancer
Disease Site: Breast
PI: Ahmed, Kamran

Clinical Trial 21093

Disease Site: Breast
PI: Han, Heather

Clinical Trial 20490

Keystroke: A Randomized Phase II Study of Pembrolizumab (Keytruda) Plus Stereotactic Re-irradiation versus SBRT Alone For Locoregionally Recurrent or Second Primary Head and Neck Carcinoma
Disease Site: Other Skin, Lip, Oral Cavity and Pharynx
PI: Caudell, Jimmy

Clinical Trial 21336

A Phase I/Ib Global, Multicenter, Open-Label Umbrella Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (Intrinsic)
Disease Site: Colon
PI: Imanirad, Iman

Clinical Trial 21239

Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Disease Site: Melanoma, skin
PI: Tarhini, Ahmad

Clinical Trial 21763

Disease Site: Myeloid and Monocytic Leukemia
PI: Bejanyan, Nelli

Clinical Trial 21378

Phase 1 Study of Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine and Pepinemab / Trastuzumab in Patients with Metastatic HER2-Positive Breast Cancer
Disease Site: Breast
PI: Han, Heather